# To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

> **NCT05236218** · — · UNKNOWN · sponsor: **King's College London** · enrollment: 60 (estimated)

## Conditions studied

- Muscle Invasive Bladder Cancer
- Surgery
- Sexual Wellbeing
- Patient Satisfaction
- Patient Preference

## Interventions

- **OTHER:** Discrete Choice Experiment (DCE) Patients DCE Questionnaire
- **OTHER:** Semi-Structured Interview Patients Interview

## Key facts

- **NCT ID:** NCT05236218
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-20
- **Primary completion:** 2023-04-25
- **Final completion:** 2024-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236218, "To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05236218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*